Development Services Overview

Biodesix enables the world’s leading biopharmaceutical, life sciences, and academic research institutions with scientific, technological, and operational capabilities that fuel the development of future therapeutics, diagnostic tests, and scientific tools. We provide unique, custom development services to:
  • enable therapeutic clinical trials
  • validate life sciences tools and diagnostics
  • discover, develop, and commercialize novel diagnostics.

Biodesix operates two highly-certified, technologically-advanced laboratories:

Two columns; Left column shows image of Biodesix Louisville, CO laboratory with the following list: CLIA certified; CAP accredited; NYS CLEP certified - Clinical Chemistry (soluble tumor markers), Oncology - Molecular and Cellular Tumor Markers; ISO 13485 certified; FDA registered for specimen transport kitting; Development services - Biodesix R&D is conducted in this lab. The right column shows close up image of green liquid in pipette for Biodesix De Soto, KS laboratory with the following list: CLIA certified; CAP accredited; NYS CLEP certified - Clinical Chemistry (soluble tumor markers), Diagnostic Immunology - Diagnostic Services Serology; Test Services - the high volume Nodify Lung Nodule Risk Assessment test is conducted in this lab, with industry0leading turnaround times.

Biodesix Development Services enable the world’s leading biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics. We provide development services to enable therapeutic clinical trials, the validation of life sciences tools and diagnostics, and the discovery, development, and commercialization of diagnostics. Biodesix Development Services have been utilized by over 65 industry clients and academic partners. We continuously revisit our technology strategy and roadmap to integrate new technologies into our evolving offering, which ultimately support the addition of new service and product revenue offerings. We believe that no single technology can interrogate the complexity of the human disease state to help solve all clinical questions. For that reason, we employ a multi-omic approach to solving diagnostic challenges. We offer end-to-end diagnostic solutions, including translational research, initial biomarker discovery, assay design, development, and validation, testing of clinical trial samples, regulatory, reimbursement, commercialization, and logistical support services. We offer our existing on-market tests, a suite of other research tests and the capability to custom design and develop novel tests for use by our customers.

Connect with our team to further discuss your development or research needs.

Biopharma Services
Life Sciences Services